Dimitrios Papadopoulos

Role & Affiliation: Associate Professor of Neurology at the National and Kapodistrian University of Athens (School of Medicine, Department of Medicine). Active researcher at the Hellenic Pasteur Institute and multiple academic institutions. Specializes in multiple sclerosis (MS), cellular senescence, and clinical trial analysis.

• Education:
  • MD, National and Kapodistrian University of Athens School of Medicine (1998)
  • PhD in Cellular and Molecular Neuroscience, Imperial College London (2003)
  • FEBN (European Board of Neurology) Certification (2012)

Research Focus: Investigates cellular senescence mechanisms in progressive MS, neurodegeneration pathways, and the efficacy/safety of disease-modifying therapies. Leads projects funded by organizations like the Multiple Sclerosis Society and Genesis Pharma.

Key Projects:

• Principal Investigator for studies on cellular senescence in MS disability progression (2017–2020)
• Co-investigator analyzing cervical spinal cord atrophy in MS (2020–present)
• FAMILY Study: Evaluates prolonged-release fampridine’s impact on cognition and quality of life in MS (2017–2019)

Advancing Knowledge: Published extensively on MS pathophysiology, neuroimaging, and clinical trial methodologies. His work bridges basic science (e.g., retinal microglia analysis) and translational research (e.g., drug tolerability reviews).